- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 457/00 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid
Patent holdings for IPC class C07D 457/00
Total number of patents in this class: 18
10-year publication summary
|
2
|
0
|
1
|
1
|
0
|
0
|
0
|
1
|
2
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| ProLynx LLC | 53 |
3 |
| Axxonis Pharma AG | 2 |
2 |
| MAP Pharmaceuticals, Inc. | 54 |
2 |
| Ceruvia Lifesciences LLC | 14 |
2 |
| The Regents of the University of California | 20303 |
1 |
| Centre National de La Recherche Scientifique | 10706 |
1 |
| Ipsen Pharma S.A.S. | 372 |
1 |
| Sunovion Pharmaceuticals Inc. | 258 |
1 |
| Universite de Poitiers | 189 |
1 |
| Waters Technologies Corporation | 1748 |
1 |
| BetterLife Pharma Inc. | 11 |
1 |
| Transcend Biodynamics LLC | 2 |
1 |
| Terran Biosciences, Inc. | 96 |
1 |
| Other owners | 0 |